Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Terminated 2Recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 282Carcinoma, Non-Small-Cell Lung 253Leukemia, Myeloid, Acute 190Breast Neoplasms 153Melanoma 151Neoplasm Metastasis 148Multiple Myeloma 127Recurrence 123Colorectal Neoplasms 119Lymphoma, Non-Hodgkin 114Lymphoma 113Leukemia, Lymphocytic, Chronic, B-Cell 108Pancreatic Neoplasms 99Ovarian Neoplasms 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 91Leukemia 86Prostatic Neoplasms 83Lung Neoplasms 82Squamous Cell Carcinoma of Head and Neck 77Lymphoma, Large B-Cell, Diffuse 77Glioblastoma 73Carcinoma, Renal Cell 72Myelodysplastic Syndromes 68Lymphoma, Follicular 65Brain Neoplasms 60Lymphoma, Mantle-Cell 55Sarcoma 53Triple Negative Breast Neoplasms 52Stomach Neoplasms 52Head and Neck Neoplasms 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Terminated × Giant Cell Tumor of Tendon Sheath × Clear all
NCT01804530 2018-08-02

Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors

Plexxikon

Phase 1 Terminated
59 enrolled

Giant Cell Tumor of Tendon Sheath

NCT02673736 2018-08-02

A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor

Plexxikon

Phase 1 Terminated
11 enrolled

Giant Cell Tumor of Tendon Sheath, Joint Diseases, Neoplasms, Synovitis, Synovitis, Pigmented Villonodular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡